4.5 Review

Adverse fetal and neonatal outcomes following in-utero exposure to oxcarbazepine: A systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Retrospective Analysis of Oxcarbazepine in Pregnant Women With Substance Use Disorders: Focus on Safety

Kayla D. Johnson et al.

Summary: A retrospective chart review compared safety outcomes associated with exposure to oxcarbazepine (OXC) versus non-exposure in nonepileptic pregnant women with substance use disorders (SUD) and comorbid psychiatric symptomatology. The study found no significant differences in emergent cesarean or maternal hyponatremia, rates of prematurity, physical characteristics, malformation, and neonatal abstinence syndrome between the OXC-exposed and non-exposed groups. Further studies with larger sample sizes are needed to determine statistical significance.

JOURNAL OF PHARMACY PRACTICE (2021)

Review Clinical Neurology

Current role of carbamazepine and oxcarbazepine in the management of epilepsy

Ahmad Beydoun et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)

Review Public, Environmental & Occupational Health

Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies

Yingjuan Liu et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)

Article Clinical Neurology

Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs

Pierre-Olivier Blotiere et al.

NEUROLOGY (2019)

Article Multidisciplinary Sciences

Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth

Andrea Margulis et al.

PLOS ONE (2019)

Article Clinical Neurology

Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications

Dana Jazayeri et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)

Article Clinical Neurology

Spontaneous fetal loss in women with epilepsy: prospective data from pregnancy registry in India

Madhukar Trivedi et al.

EPILEPSY RESEARCH (2018)

Article Health Care Sciences & Services

A new improved graphical and quantitative method for detecting bias in meta-analysis

Luis Furuya-Kanamori et al.

INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2018)

Review Clinical Neurology

Effect of anti-epileptic drug therapy on the unborn child

Frank J. E. Vajda

JOURNAL OF CLINICAL NEUROSCIENCE (2014)

Article Clinical Neurology

Associations between particular types of fetal malformation and antiepileptic drug exposure in utero

F. J. E. Vajda et al.

ACTA NEUROLOGICA SCANDINAVICA (2013)

Review Medicine, General & Internal

Oxcarbazepine for acute affective episodes in bipolar disorder

Akshya Vasudev et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)

Review Pharmacology & Pharmacy

New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?

Jacqueline A. French et al.

THERAPEUTIC ADVANCES IN DRUG SAFETY (2011)

Review Clinical Neurology

Drug interactions involving the new second- and third-generation antiepileptic drugs

Cecilie Johannessen Landmark et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)

Article Clinical Neurology

In utero antiepileptic drug exposure - Fetal death and malformations

K. J. Meador et al.

NEUROLOGY (2006)

Article Behavioral Sciences

Oxcarbazepine in pregnancy: clinical experience in Argentina

R Meischenguiser et al.

EPILEPSY & BEHAVIOR (2004)

Article Clinical Neurology

Major malformations in offspring of women with epilepsy

E Kaaja et al.

NEUROLOGY (2003)